We are live on ! Find out more
Capital International Investors

Capital International Investors Portfolio holdings

AUM $484B
1-Year Est. Return 34.9%
 

Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.

This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
+34.9%
3 Year Est. Return
+137.52%
5 Year Est. Return
+174.34%
10 Year Est. Return
+599.87%
AUM
$201B
AUM Growth
-$17.8B
Cap. Flow
+$10.5B
Cap. Flow %
5.25%
Top 10 Hldgs %
26.76%
Holding
405
New
26
Increased
182
Reduced
88
Closed
28

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$1.53B
2
CI icon
Cigna
CI
+$1.08B
3
EOG icon
EOG Resources
EOG
+$854M
4
LIN icon
Linde
LIN
+$811M
5
META icon
Meta Platforms (Facebook)
META
+$792M

Sector Composition

Rank Sector Weight
1 Technology 18.95%
2 Healthcare 17.17%
3 Financials 13.64%
4 Communication Services 10.53%
5 Energy 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOG
351
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$7.21M ﹤0.01%
1,680,000
AORT icon
352
Artivion
AORT
$1.4B
$6.59M ﹤0.01%
232,174
RVNC
353
DELISTED
Revance Therapeutics, Inc.
RVNC
$6.54M ﹤0.01%
325,000
SAND
354
DELISTED
Sandstorm Gold
SAND
$6.28M ﹤0.01%
1,361,300
+9,900
+0.7% +$40.2K
RUBY
355
DELISTED
Rubius Therapeutics, Inc
RUBY
$6.09M ﹤0.01%
416,396
-170,000
-29% -$3.1M
XENE icon
356
Xenon Pharmaceuticals
XENE
$6.23B
$5.92M ﹤0.01%
937,400
TCBI icon
357
Texas Capital Bancshares
TCBI
$4.41B
$5.72M ﹤0.01%
112,054
GLNG icon
358
Golar LNG
GLNG
$5.36B
$5.37M ﹤0.01%
246,600
+224,000
+991% +$5.79M
CZZ
359
DELISTED
Cosan Limited
CZZ
$5.01M ﹤0.01%
569,000
EB
360
DELISTED
Eventbrite
EB
$4.94M ﹤0.01%
177,600
+77,600
+78% +$2.3M
ONCE
361
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.23M ﹤0.01%
108,000
CLLS
362
Cellectis
CLLS
$313M
$3.99M ﹤0.01%
+239,391
New +$5.55M
CRSP icon
363
CRISPR Therapeutics
CRSP
$5.23B
$3.94M ﹤0.01%
138,000
WOLF icon
364
Wolfspeed
WOLF
$1.72B
$3.61M ﹤0.01%
84,442
GOGO icon
365
Gogo Inc
GOGO
$378M
$3.6M ﹤0.01%
1,205,000
EDIT icon
366
Editas Medicine
EDIT
$442M
$3.46M ﹤0.01%
152,000
ESNT icon
367
Essent Group
ESNT
$6.18B
$3.25M ﹤0.01%
95,000
GTHX
368
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.58M ﹤0.01%
135,000
-130,000
-49% -$4.87M
ADAP
369
DELISTED
Adaptimmune Therapeutics
ADAP
$2.27M ﹤0.01%
394,000
CLVS
370
DELISTED
Clovis Oncology, Inc.
CLVS
$2.14M ﹤0.01%
119,000
CBLK
371
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$2.06M ﹤0.01%
153,723
AXON
372
Axon Enterprise
AXON
$50B
-127,599
Closed -$8.73M
BNS icon
373
Scotiabank
BNS
$110B
-1,007,545
Closed -$60.1M
BTI icon
374
British American Tobacco
BTI
$124B
$0 ﹤0.01%
7
BWA icon
375
BorgWarner
BWA
$14B
-5,112,000
Closed -$193M

Similar funds

Capital International Investors's Q4 2018 Portfolio in Review

As of Q4 2018, Capital International Investors held 405 positions worth $201B, down 8.1% from $218B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Capital International Investors deployed $10.5B of net new capital in Q4 2018, opening 26 new positions and adding to 182 existing holdings. Its largest new stake was Cigna: 5,184,723 shares worth $985M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was American International, an estimated $493M trimmed.

  • Capital International Investors's largest Q4 2018 buy was Cigna: 5,184,723 shares worth $985M.
  • Capital International Investors added most to Northrop Grumman in Q4 2018, an estimated $1.53B increase.
  • Capital International Investors's biggest Q4 2018 reduction was American International, cutting an estimated $493M.
  • Capital International Investors fully exited Aetna Inc in Q4 2018, selling an estimated $2.55B.
  • Capital International Investors's ten largest holdings make up 27% of its $201B portfolio in Q4 2018.
  • Capital International Investors opened 26 new positions and closed 28 in Q4 2018.
  • Capital International Investors's portfolio value fell 8.1% quarter-over-quarter to $201B.

Based on Capital International Investors's 13F filing for Q4 2018, filed 14 Feb 2019.